期刊文献+

组织多普勒成像与脑钠素联合评价原发性高血压患者左心室舒张功能

下载PDF
导出
出处 《临床荟萃》 CAS 2009年第20期1814-1815,共2页 Clinical Focus
  • 相关文献

参考文献11

  • 1Kohno M, Horio T, Yokokawa K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension[J]. Am J Med,1992,92(1) :29-34.
  • 2陈协兴,洪华山,郑关毅,王一波,陈良龙,江琼.原发性高血压患者左心室功能障碍与血清脑利钠肽水平的研究[J].高血压杂志,2003,11(6):543-545. 被引量:29
  • 3Sudoh T, Kangawa K, Minamino N, et at. A new natriuretic peptide in porcine brain[J]. Nature,1988,332(6159) :78-81.
  • 4Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure[J]. Circulation, 1994, 90(1) : 195-203.
  • 5Hystad ME,Geiran OR, Attramadal H, et al. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure[J]. Acta Physiol Scand,2001, 171(4) :395-403.
  • 6Friedl W, Mair J, Thomas S, et al. Natriuretic peptides and cyclic gunanosine 3'5'- monophosphate in asymptomatic and symptomatic left ventricular dysfunction[J]. Heart, 1996,76 (2):129-136.
  • 7de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease[J]. Lancet, 2003,362 (9380) : 316-322.
  • 8Grewal J, McKelvie R, Lonn E, et al. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction[J]. Eur J Heart Fail, 2008,10(3) :252-259.
  • 9谌承志,肖琳玲,邓万俊.脑钠肽诊断心力衰竭的研究进展[J].临床荟萃,2006,21(3):212-215. 被引量:4
  • 10徐瑞,张运,张梅,葛志明,张薇,钟明,李秀昌.多普勒组织成像对高血压左心室肥厚患者左心室舒张功能的评价[J].中华超声影像学杂志,2002,11(8):467-470. 被引量:27

二级参考文献29

  • 1Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type nariuretic peptide in the emergency diagnosis of heart failure[J]. N Engl J Med, 2002,347 (3)161-167.
  • 2Morrison LK, Harrison A,Krishnaswamy P,et al. Utility of arapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea[J]. J Am Coil Cardiol,2002, 39(2) :202-209.
  • 3Ford CM, Pruitt R, Parker V, et al. CHF: Effects of cardiac rehabilitation and brain natriuretic peptide [J]. Nurse Practitioner, 2004, 29(3) :36-39.
  • 4Munagala VK, Burnett JC Jr, Jrredfield MM, et al. The natriuretie peptides in cardiovascular medicine[J]. Curt Prob Cardiol, 2004,29(12) :707-769.
  • 5Mcdonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction[J]. Lancet,1998,351(9095) ;9-13.
  • 6Nielsen OW~ Mcdonagh TA, Robb SD, et al. Retrospective analysis of the cost-effectiveness of using plasma brain natfiuretie peptide in screening for left ventrieular systolic dysfunction in the general population[J]. J Am Coil Cardiol,2003,41(1): 113-120.
  • 7Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death[J]. N Engl J Med, 2004,350(7):655-663.
  • 8Smith H, Picketing RM, Struthers A, et al. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study [J]. BMJ, 2000, 320(7239) :906-908.
  • 9Vasan RS, Benjamin EJ,Larson MG, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study[J]. JAMA, 2002,288(10):1252-1259.
  • 10Lubien E, Demaria A, Krishnaswamy P,et al. Utility of Bnatriuretic peptide in detecting diastolic dysfunction:comparison with Doppler velocity recordings[J]. Circulation,2002,105(5) :595-601.

共引文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部